Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023. Pipeline ...
Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023.Pipeline progress included the approval ...
Verywell Mind on MSN2d
Are Mushroom Supplements the Key to Boosting Your Brain Health?If you take dietary supplements intending to improve your overall health, you aren't alone. Close to 75% of all US adults say ...
Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback